Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
ASSETS    
Current asset - cash $ 25,000 $ 25,000
Deferred offering costs 221,923
TOTAL ASSETS 246,923 25,000
Current liabilities:    
Accrued expenses 1,000 1,000
Accrued offering costs 39,067
Promissory note - related party 182,856
Total Liabilities 222,923 1,000
Commitments and Contingencies
Stockholder’s Equity    
Common stock, $0.0001 par value; 30,000,000 shares authorized; 4,312,500 issued and outstanding [1],[2] 431 431
Additional paid-in capital 24,569 24,569
Accumulated deficit (1,000) (1,000)
Total Stockholder’s Equity 24,000 24,000
TOTAL LIABILITIES AND STOCKHOLDER’S EQUITY $ 246,923 $ 25,000
[1] In February 2021, the Company effected a 1.4375-for-1 stock split, resulting in 7,187,500 shares of common stock outstanding. In June 2021, the Company’s Sponsor forfeited 2,875,000 Founder Shares for no consideration resulting in 4,312,500 shares of common stock outstanding (see Note 5). All share and per-share amounts have been retroactively restated to reflect the share forfeiture.
[2] Includes up to 562,500 shares of common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5). The underwriters exercised their over-allotment option in full on July 28, 2021; thus, no shares of common stock remain subject to forfeiture (see Note 6).